<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of mechanical ventilation in preterm neonates</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of mechanical ventilation in preterm neonates</h1>
<div class="graphic"><div class="figure"><div class="ttl">Overview of mechanical ventilation in preterm neonates</div><div class="cntnt"><table cellspacing="0"><tbody> <tr> <td class="subtitle1_single">Key principles</td> </tr> <tr> <td class="indent1"><strong>Minimizing VILI:</strong> Therapeutic strategies to support gas exchange while minimizing VILI include: <ul class="decimal_heading"> <li>Avoidance of MV through preferential use of nCPAP when possible</li> <li>For neonates who fail nCPAP and require invasive MV, lung protective strategies include: <ul> <li>Preferential use of VTV with Tv of 4 to 6 mL/kg to minimize volutrauma</li> <li>Use of PEEP to maintain lung recruitment and avoid atelectasis</li> <li>Avoidance of high FiO<sub>2</sub></li> <li>Setting targets for gas exchange that do not aim for normal levels (ie, modest permissive hypercapnia)</li> <li>Use of HFOV or HFJV in neonates at high risk of developing VILI or as rescue therapy for neonates with refractory respiratory failure while on CMV</li> </ul> </li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="indent1"><strong>Achieving gas exchange:</strong> With CMV, the primary means of achieving ventilation (CO<sub>2</sub> clearance) and oxygenation (uptake of O<sub>2</sub>) are as follows: <ul class="decimal_heading"> <li>Ventilation – CO<sub>2</sub> clearance is primarily determined by minute ventilation (ie, RR and Tv).</li> <li>Oxygenation – Oxygenation is primarily determined by MAP and FiO<sub>2</sub>. In CMV, MAP is largely determined by PEEP.</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Indications for MV</td> </tr> <tr class="divider_bottom"> <td class="indent1">If, despite efforts to optimize noninvasive support, the neonate develops any of the following signs of inadequate gas exchange, we typically intubate and initiate invasive MV*: <ul class="decimal_heading"> <li>pH &lt;7.20, with PaCO<sub>2</sub> &gt;65 mmHg</li> <li>Requiring FiO<sub>2</sub> &gt;0.4 to 0.5 to achieve target SpO<sub>2</sub> goal</li> <li>Multiple apneic episodes per hour associated with desaturations and bradycardia or more than 1 episode requiring positive pressure ventilation within a few hours</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Initial mode and settings</td> </tr> <tr> <td class="indent1">The ventilator mode and settings must be tailored to meet the needs of the individual neonate, which may differ between patients and within the same patient over time. In our center, we typically initiate MV with CMV and reserve HFV for cases of refractory respiratory failure despite efforts to optimize CMV. However, other centers may use HFV as an initial ventilation strategy in neonates at high risk for developing VILI.</td> </tr> <tr> <td class="indent1"><strong>Mode:</strong> <ul class="decimal_heading"> <li>We typically use a synchronized mode with both mandatory and spontaneous breaths (ie, SIMV + PS or ACV)</li> <li>We preferentially use VTV in all preterm neonates</li> <li>We use PLV if there is a technical challenge that limits the reliable delivery of measured Tv (eg, large ETT leak) or VTV is not available</li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="indent1"><strong>Initial settings:</strong> <ul class="decimal_heading"> <li>Tv 4 to 6 mL/kg</li> <li>PEEP 5 to 6 cm H<sub>2</sub>O</li> <li>Ti 0.35 to 0.4 seconds</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Monitoring</td> </tr> <tr class="divider_bottom"> <td class="indent1">Appropriate monitoring includes: <ul class="decimal_heading"> <li>Continuous SpO<sub>2</sub> monitoring</li> <li>Serial assessments of work of breathing</li> <li>Blood gases<sup>¶</sup> – CBG and VBG are adequate in many cases, but placement of an arterial catheter for ABG sampling may be warranted in some cases (if the neonate is requiring blood sampling more frequently than every 6 hours or has hemodynamic instability requiring active titration of vasoactive medications)</li> <li>Ventilator monitoring, including PIP and exhaled Tv measured by the ventilator</li> <li>Chest radiographs – Chest radiographs should be obtained judiciously to inform decisions about ventilator settings and/or identify acute changes (eg, air leak, malpositioned ETT)</li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Gas exchange targets</td> </tr> <tr> <td class="indent1"><strong>Oxygen target:</strong> SpO<sub>2</sub> target 90 to 95%</td> </tr> <tr> <td class="indent1"><strong>Carbon dioxide targets:</strong> <ul class="decimal_heading"> <li>For most preterm neonates in the first few weeks of life: pCO<sub>2</sub> target is between 40 and 65 mmHg (ie, modest permissive hypercapnia)</li> <li>For older preterm infants with evolving BPD, it is reasonable to use more liberally permissive pCO<sub>2</sub> targets as long as the pH remains &gt;7.25</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">This table summarizes the general approach to MV in preterm neonates and it reflects the practice at the author's institution. However, practice is not standardized, and other centers may use a different approach. For further details, including the evidence supporting these MV settings and targets, refer to UpToDate content on MV in neonates.</div><div class="graphic_footnotes">VILI: ventilator-induced lung injury; MV: mechanical ventilation; nCPAP: nasal continuous positive airway pressure; VTV: volume-targeted ventilation; Tv: tidal volume; PEEP: positive end-expiratory pressure; FiO<sub>2</sub>: fraction of inspired oxygen; HFOV: high-frequency oscillatory ventilation; HFJV: high-frequency jet ventilation; CMV: conventional mechanical ventilation; RR: respiratory rate; MAP: mean airway pressure; PaCO<sub>2</sub>: partial pressure of arterial carbon dioxide; SpO<sub>2</sub>: peripheral oxygen saturation; HFV: high-frequency ventilation; SIMV + PS: synchronized intermittent mandatory ventilation plus pressure support; ACV: assist control ventilation; PLV: pressure-limited ventilation; ETT: endotracheal tube; Ti: inspiratory time; CBG: capillary blood gas; VBG: venous blood gas; ABG: arterial blood gas; PIP: peak inspiratory pressure; pCO<sub>2</sub>: partial pressure of carbon dioxide.<br/>* We rely mostly on these objective measures of gas exchange to define CPAP failure. However, the thresholds are not hard set, and these parameters should be interpreted in conjunction with other clinical findings. For neonates with signs of labored breathing, hemodynamic instability, or persistent metabolic acidosis, we generally use a lower threshold for transitioning to invasive MV.<br/>¶ Transcutaneous carbon dioxide monitoring (TCOM) may be used in select circumstances (eg, neonates with severely compromised ventilation or when dynamic changes in pCO<sub>2</sub> levels are anticipated, particularly when transitioning to, or titrating, HFOV). Other centers use TCOM routinely.</div><div id="graphicVersion">Graphic 131155 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
